Unknown

Dataset Information

0

Changes in channel trafficking and protein stability caused by LQT2 mutations in the PAS domain of the HERG channel.


ABSTRACT: Inherited human long-QT2 syndrome (LQTS) results from mutations in the gene encoding the HERG channel. Several LQT2-associated mutations have been mapped to the amino terminal cytoplasmic Per-Arnt-Sim (PAS) domain of the HERG1a channel subunit. Here we have characterized the trafficking properties of some LQT2-associated PAS domain mutants and analyzed rescue of the trafficking mutants by low temperature (27°C) or by the pore blocker drug E4031. We show that the LQT2-associated mutations in the PAS domain of the HERG channel display molecular properties that are distinct from the properties of LQT2-associated mutations in the trans-membrane region. Unlike the latter, many of the tested PAS domain LQT2-associated mutations do not result in trafficking deficiency of the channel. Moreover, the majority of the PAS domain mutations that cause trafficking deficiencies are not rescued by a pore blocking drug. We have also explored the in vitro folding stability properties of isolated mutant PAS domain proteins using a thermal unfolding fluorescence assay and a chemical unfolding assay.

SUBMITTER: Harley CA 

PROVIDER: S-EPMC3292575 | biostudies-literature | 2012

REPOSITORIES: biostudies-literature

altmetric image

Publications

Changes in channel trafficking and protein stability caused by LQT2 mutations in the PAS domain of the HERG channel.

Harley Carol A CA   Jesus Catarina S H CS   Carvalho Ricardo R   Brito Rui M M RM   Morais-Cabral João H JH  

PloS one 20120302 3


Inherited human long-QT2 syndrome (LQTS) results from mutations in the gene encoding the HERG channel. Several LQT2-associated mutations have been mapped to the amino terminal cytoplasmic Per-Arnt-Sim (PAS) domain of the HERG1a channel subunit. Here we have characterized the trafficking properties of some LQT2-associated PAS domain mutants and analyzed rescue of the trafficking mutants by low temperature (27°C) or by the pore blocker drug E4031. We show that the LQT2-associated mutations in the  ...[more]

Similar Datasets

| S-EPMC7188350 | biostudies-literature
| S-EPMC7791479 | biostudies-literature
| S-EPMC8612226 | biostudies-literature
| S-EPMC8693265 | biostudies-literature
| S-EPMC2838577 | biostudies-literature
| S-EPMC4029991 | biostudies-literature
| S-EPMC4793660 | biostudies-literature
| S-EPMC3557513 | biostudies-literature
| S-EPMC4973297 | biostudies-literature
| S-EPMC3714577 | biostudies-literature